4:15 PLENARY KEYNOTE SESSION
4:20 CAR-T Therapy for B Cell Malignancies
Jennifer Brogdon, PhD, Director, Exploratory Immuno-Oncology, Novartis
Biography: Dr. Jennifer Brogdon is currently Director of Exploratory Immuno-Oncology at Novartis Institutes for BioMedical Research in Cambridge, MA where she leads a diverse, cross-functional team to develop next-generation CAR-T therapies. She is the Global Preclinical Research Lead for CTL019 and co-leads the joint research collaboration with the University of Pennsylvania to bring new cell therapies to clinical development for both hematological and solid tumors. Since she joined NIBR in 2004, Dr. Brogdon has developed broad expertise in antibody, small molecule and cell and gene therapy programs, most notably during the BLA submission, ODAC and approval of Kymriah. Dr. Brogdon holds a PhD in Immunology from Duke University and completed her postdoctoral training at Yale University.
4:55 Walking on the Moon: Reflections on the Work of the Cancer Moonshot and the Future of the Biden Cancer Initiative
Catharine Young, PhD, Senior Director, Science Policy, Biden Cancer Initiative
Nixon's War on Cancer faced an outlook for success as bleak as the Moon's surface with no understanding of the genetic complexity of cancer, no therapeutic weapons, and no grand strategy. The Cancer Moonshot provided the leadership to harness the millions of scientists and patients, powerful new therapies, and cultural changes needed to double our rate of progress against cancer. The Biden Cancer Initiative is now continuing the movement to double our rate of progress in preventing, detecting, diagnosing, and treating cancer. Dr. Catharine Young, Senior Director of Science Policy of the Biden Cancer Initiative, will provide a progress report and outlook for the future of the Biden Cancer Initiative.
Biography: Dr. Catharine Young holds a doctorate degree in Biomedical Sciences and currently serves as the Senior Director of Science Policy for the Biden Cancer Initiative. Here her portfolio covers all things science, data, and tech as related to ending cancer as we know it. Prior to this position, Catharine served as the Senior Science and Innovation Policy Advisor and Head of the D.C. team for the Foreign Commonwealth Office. Based at the British Embassy, Catharine influenced science and innovation policies of both the U.K. and U.S. governments, industry, and academia. Following her Postdoctoral training at Cornell University in Biomedical Engineering, Catharine was selected as an AAAS Science and Technology Policy Fellow in the Office of the Assistant Secretary of Defense for Nuclear, Chemical, and Biological Defense Programs. Here she led international engagements on eliminating biological weapons, improving biosafety and biosecurity, and establishing and enhancing biosurveillance capacity. Catharine also co-founded Blueprint International, a non-profit dedicated to providing novel technological solutions to some of the world's most pressing social issues. Her recent awards include being selected as a TED Fellow, Alexandria 40 Under 40, and Social Enablers top 100 most inspiring social entrepreneurs. Catharine is an advocate for women in STEM and has been a contributor to major social and media networks including TED-Ed, the Guardian, and the U.K. Science and Innovation Network.